Longevity & AgingReview ArticleOpen Access

How Aging Turns Muscle's Repair Network Against Itself

A comprehensive review reveals how aging rewires the entire cellular ecosystem of skeletal muscle, converting a regenerative niche into a degenerative one.

Friday, October 2, 2026 5 views
Published in Aging Cell
Cross-section diagram of aged skeletal muscle tissue under a microscope showing fragmented muscle fibers, infiltrating immune cells, and fibrous connective tissue replacing contractile tissue

Summary

Skeletal muscle aging is not simply a story of stem cell loss. This review synthesizes single-cell, spatial, and multimodal omics evidence to show that aging systematically disrupts the entire multicellular community inside muscle tissue. Muscle stem cells, fibro-adipogenic progenitors, immune cells, blood vessels, and neuromuscular junctions all shift into maladaptive states that reinforce one another through dysfunctional signaling loops. The result is chronic inflammation that never resolves, progressive fibrosis, impaired vascular support, and incomplete nerve reconnection — collectively driving sarcopenia. The authors argue that restoring healthy communication networks among these cell populations, rather than targeting any single cell type, is the most promising path to reversing age-related muscle decline.

0:00--:--

Detailed Summary

Skeletal muscle is the body's largest metabolic organ and a cornerstone of longevity, yet it loses roughly 1–2% of its mass per year after age 50, culminating in sarcopenia, frailty, and increased all-cause mortality. This review, drawing on a structured literature search of PubMed and Web of Science covering 2014–2026, argues that conventional explanations centered on muscle stem cell (MuSC) exhaustion are insufficient. Instead, the authors frame muscle aging as a collapse of multicellular coordination — a shift from a regenerative niche to a degenerative niche — driven by population-level remodeling across at least five interacting cell compartments.

In aged mice (≥20 months), MuSCs not only decline in absolute number but qualitatively shift: a measurable fraction loses the capacity for reversible quiescence and enters a pre-senescent state. Time-resolved trajectory analyses show that while the overall sequence of MuSC activation and differentiation is preserved, the kinetics are delayed and highly heterogeneous compared to young controls. A key mechanistic insight is that elevated NDRG1 expression in aged MuSCs suppresses mTOR signaling — functioning as a 'cellular brake' that prioritizes survival over rapid repair. Pharmacological NDRG1 inhibition temporarily restores youthful activation but accelerates MuSC pool depletion under repeated injury, illustrating a survivorship-bias model where remaining cells are selected for persistence, not regeneration. Epigenetically, age-associated S-adenosylmethionine (SAM) depletion reduces H3K9me2/3 and HP1 levels, destabilizing heterochromatin and promoting DNA damage; restoring intracellular SAM re-establishes these domains and partially rescues regenerative capacity.

The immune compartment undergoes equally profound remodeling. In aged muscle, M2-like macrophage subsets persist in a pro-fibrotic state, sustaining secretion of TGF-β and osteopontin (SPP1) beyond the optimal repair window. Simultaneously, regulatory T cell (Treg) accumulation is markedly reduced or delayed, removing the IL-10-driven pro-resolving signals that normally orchestrate macrophage state transitions. Residual neutrophils generate chronic oxidative stress, and aged T cells secrete IFN-γ and TNF-α, directly impairing MuSC differentiation. The net effect is immune-state persistence — inflammation that never fully resolves.

Fibro-adipogenic progenitors (FAPs), normally essential for transient ECM remodeling during repair, become locked in pro-fibrotic states in aged muscle. Senescent FAP subpopulations accumulate and, through the senescence-associated secretory phenotype (SASP), amplify inflammatory and fibrotic signaling to neighboring cells. The vascular compartment deteriorates in parallel: aged endothelial cells downregulate angiogenic programs and upregulate inflammatory gene expression, reducing the capillary density and oxygen delivery that MuSCs require for timely activation. Pericyte dysfunction further compounds this vascular insufficiency. Finally, neuromuscular junctions (NMJs) in aged muscle show fragmented morphology, incomplete reinnervation after denervation, and declining Schwann cell support — all of which accelerate the loss of fast-twitch fiber-innervated motor units.

The review makes a critical methodological distinction: many intercellular ligand-receptor interactions proposed by computational analyses of single-cell atlases remain correlative, and only a limited subset has been functionally validated in vivo through genetic or pharmacological perturbation. The authors caution against treating atlas-inferred networks as established causal mechanisms. Therapeutically, they propose that interventions aimed at restoring multicellular coordination — senolytics targeting FAP-resident senescent cells, Treg expansion to reinstate immune resolution, angiogenic support via VEGF pathways, and NMJ stabilization — hold more promise than strategies focused on a single cell type. This framework reframes sarcopenia as a systems-level communication failure, opening new avenues for combinatorial intervention.

Key Findings

  • In geriatric mice (≥20 months), a measurable fraction of MuSCs loses reversible quiescence and shifts to a pre-senescent state, impairing activation, proliferation, and self-renewal efficiency.
  • Elevated NDRG1 in aged MuSCs suppresses mTOR signaling as a 'cellular brake'; pharmacological NDRG1 inhibition restores early repair kinetics but causes severe MuSC pool depletion after repeated injury cycles.
  • Age-associated SAM depletion reduces repressive H3K9me2/3 histone methylation and HP1 levels, destabilizing MuSC heterochromatin; restoring intracellular SAM re-establishes heterochromatin domains and mitigates regenerative defects.
  • Aged M2-like macrophage subsets sustain secretion of TGF-β and SPP1 (osteopontin) beyond the optimal repair window, driving adjacent FAPs to deposit excessive collagen and promoting fibrosis.
  • Treg accumulation is markedly reduced or delayed in aged muscle, depleting IL-10-driven pro-resolving signals required for macrophage state transitions from inflammatory to reparative phenotypes.
  • Senescent FAP subpopulations accumulate in aged muscle and amplify inflammatory and pro-fibrotic signals via SASP, locking the tissue in a degenerative signaling circuit.
  • Cross-species analyses of acute mouse regeneration atlases and chronic human aging datasets show convergent reductions in cells successfully navigating canonical MuSC activation trajectories, alongside shared expansion of senescent-like and pro-inflammatory subpopulations.

Methodology

This is a structured narrative review, not a primary study. The authors searched PubMed and Web of Science for articles published 2014–2026 using terms including 'skeletal muscle aging,' 'sarcopenia,' 'single-cell RNA sequencing,' 'spatial transcriptomics,' and 'intercellular communication.' Inclusion criteria prioritized peer-reviewed original research and high-resolution multi-omics atlases from in vivo mammalian models (mouse and human); non-peer-reviewed preprints and studies without mechanistic treatment of multicellular interactions were excluded. A key stated aim was minimizing confirmation bias by integrating findings that both support and challenge current paradigms.

Study Limitations

As a narrative review, the study cannot establish causality and is subject to selection bias in the literature it synthesizes, despite efforts to minimize confirmation bias. The authors explicitly acknowledge that most ligand-receptor interactions identified from single-cell atlases remain computationally inferred rather than experimentally validated in vivo, limiting direct therapeutic translation. The primary evidence base relies heavily on rodent models, and the degree to which mouse aging dynamics fully recapitulate human sarcopenia remains an open question. No conflicts of interest are disclosed.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: